1. Home
  2. IMUX vs DSP Comparison

IMUX vs DSP Comparison

Compare IMUX & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$14.17

Market Cap

188.8M

Sector

Health Care

ML Signal

HOLD

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

HOLD

Current Price

$11.18

Market Cap

219.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMUX
DSP
Founded
2016
1999
Country
United States
United States
Employees
66
380
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
188.8M
219.6M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
IMUX
DSP
Price
$14.17
$11.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
8
Target Price
$36.00
$17.81
AVG Volume (30 Days)
232.3K
305.1K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
38.00
157.14
EPS
N/A
N/A
Revenue
N/A
$344,201,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
N/A
$16.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.00
52 Week Low
$0.51
$8.11
52 Week High
$15.77
$15.18

Technical Indicators

Market Signals
Indicator
IMUX
DSP
Relative Strength Index (RSI) 62.56 46.44
Support Level $0.74 $10.86
Resistance Level $15.77 $11.23
Average True Range (ATR) 1.18 0.84
MACD -0.21 -0.16
Stochastic Oscillator 69.09 13.94

Price Performance

Historical Comparison
IMUX
DSP

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.

Share on Social Networks: